These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 4755446)

  • 1. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck.
    Lundy J; Wanebo H; Pinsky C; Strong E; Oettgen H
    Am J Surg; 1974 Oct; 128(4):530-3. PubMed ID: 4429642
    [No Abstract]   [Full Text] [Related]  

  • 3. Demonstration of tumor-associated delayed cutaneous hypersensitivity reactions in patients with lung cancer and in pateients with carcinoma of the cervix.
    Wells SA; Burdick JF; Christiansen C; Ketcham AS; Adkins PC
    Natl Cancer Inst Monogr; 1973 Jun; 37():197-203. PubMed ID: 4713780
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of serum inhibitors of neutrophil chemotaxis associated with anergy.
    Van Epps DE; Palmer DL; Williams RC
    J Immunol; 1974 Jul; 113(1):189-200. PubMed ID: 4832308
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic abnormalities in head and neck cancer.
    Eilber FR; Morton DL; Ketcham AS
    Am J Surg; 1974 Oct; 128(4):534-8. PubMed ID: 4422512
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunodeficiency in Hodgkin disease.
    Eltringham JR; Kaplan HS
    Birth Defects Orig Artic Ser; 1975; 11(1):278-88. PubMed ID: 1148383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocompetence and prognosis in patients with gynecologic cancer.
    Nalick RH; Disaia PJ; Rea TH; Morrow CP
    Gynecol Oncol; 1974 Apr; 2(1):81-92. PubMed ID: 4459211
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA; Chute R; Rao CN
    Trans Am Assoc Genitourin Surg; 1973; 65():66-72. PubMed ID: 4763514
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic significance of skin reactivity in patients with bronchogenic carcinoma grouped according to the TNM classification.
    Plesnicar S; Rudolf Z; Lavrencic D
    Neoplasma; 1977; 24(6):633-40. PubMed ID: 593468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
    Wells SA; Melewicz FC; Christiansen C; Ketcham AS
    Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
    [No Abstract]   [Full Text] [Related]  

  • 11. [Delayed skin reactivity to mumps antigen].
    Orriols R; Morell F; de Gracia X; Sanz R; Muñiz R; Joan-Miquel L
    Med Clin (Barc); 1983 Jun; 81(1):14-6. PubMed ID: 6888053
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
    Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
    Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
    Lee YT; Sparks FC; Eilber FR; Morton DL
    Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of cutaneous neoplasms following delayed-type hypersensitivity challenge reactions to microbial antigens or lymphokines.
    Holtermann OA; Papermaster B; Rosner D; Milgrom H; Klein E
    J Med; 1975; 6(2):157-68. PubMed ID: 1099159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus.
    Simark-Mattsson C; Jontell M; Bergenholtz G; Dahlgren UI
    J Dent Res; 1999 Nov; 78(11):1704-10. PubMed ID: 10576166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cutaneous delayed hypersensitivity to costus root oil in lung cancer].
    Takanami I; Ishihara T; Yanai N
    Gan No Rinsho; 1985 Sep; 31(11):1362-6. PubMed ID: 4068238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors influencing 5-year survival and 6-month mortality after resection of lung cancer].
    Zhang YF; Zhang ZS; Yang M
    Zhonghua Wai Ke Za Zhi; 1987 Oct; 25(10):583-5, 613. PubMed ID: 3449340
    [No Abstract]   [Full Text] [Related]  

  • 20. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.